524400 Stock Overview
Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Ishita Drugs and Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹71.50 |
| 52 Week High | ₹98.37 |
| 52 Week Low | ₹46.01 |
| Beta | 0.28 |
| 1 Month Change | 11.63% |
| 3 Month Change | -6.55% |
| 1 Year Change | 44.15% |
| 3 Year Change | 120.00% |
| 5 Year Change | 301.69% |
| Change since IPO | 732.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524400 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.8% | -2.1% | -0.03% |
| 1Y | 44.2% | 57.5% | 46.9% |
Return vs Industry: 524400 underperformed the Indian Pharmaceuticals industry which returned 60.4% over the past year.
Return vs Market: 524400 underperformed the Indian Market which returned 48% over the past year.
Price Volatility
| 524400 volatility | |
|---|---|
| 524400 Average Weekly Movement | 8.7% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524400's share price has been volatile over the past 3 months.
Volatility Over Time: 524400's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 16 | Jagdishprasad Agrawal | www.ishitadrugs.com |
Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals.
Ishita Drugs and Industries Limited Fundamentals Summary
| 524400 fundamental statistics | |
|---|---|
| Market cap | ₹213.81m |
| Earnings (TTM) | ₹6.45m |
| Revenue (TTM) | ₹133.18m |
33.1x
P/E Ratio1.6x
P/S RatioIs 524400 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524400 income statement (TTM) | |
|---|---|
| Revenue | ₹133.18m |
| Cost of Revenue | ₹109.90m |
| Gross Profit | ₹23.28m |
| Other Expenses | ₹16.83m |
| Earnings | ₹6.45m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.16 |
| Gross Margin | 17.48% |
| Net Profit Margin | 4.85% |
| Debt/Equity Ratio | 21.3% |
How did 524400 perform over the long term?
See historical performance and comparison